{"url_path":"/sec/obio/8-k/2026-06-23/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-23","source_url":"https://www.sec.gov/Archives/edgar/data/1814114/0001104659-26-076845-index.html","accession_number":"0001104659-26-076845","cik":"0001814114","ticker":"OBIO","issuer_name":"Orchestra BioMed Holdings, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1814114/0001104659-26-076845-index.html","primary_entity_key":"0001814114","primary_entity_name":"Orchestra BioMed Holdings, Inc."},"word_count":310,"has_tables":true,"body_markdown":"false\n0001814114\n\n0001814114\n\n2026-06-23\n2026-06-23\n\niso4217:USD\n\nxbrli:shares\n\niso4217:USD\n\nxbrli:shares\n\n \n\n \n\n \n\n**UNITED STATES\nSECURITIES AND EXCHANGE COMMISSION\nWashington, D.C. 20549**\n\n** **\n\n**FORM 8-K**\n\n** **\n\n**CURRENT REPORT PURSUANT TO SECTION 13\nOR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\n** **\n\n**Date of Report (Date of earliest event reported): June 23, 2026**\n\n** **\n\n**ORCHESTRA BIOMED\nHOLDINGS, INC.****(Exact name of registrant as specified in its charter)**\n\n \n\n**Delaware\n(State or other jurisdiction\nof incorporation)**\n**001-39421\n(Commission\nFile Number)**\n**92-2038755\n(IRS Employer\nIdentification No.)**\n\n**150 Union Square Drive\nNew Hope, Pennsylvania 18938\n(Address of principal executive offices, including zip code)\n\nRegistrant’s telephone number, including area code: (215) 862-5797\n\n(Former name or former address, if changed since last report)**\n\n \n\n \n\nCheck the appropriate box below if the Form 8-K filing is intended\nto simultaneously satisfy the filing obligation of the registrant under any of the following provisions:\n\n \n\n¨Written communications pursuant to Rule 425 under the Securities\nAct (17 CFR 230.425)\n\n¨ Soliciting material pursuant to Rule 14a-12 under the Exchange\nAct (17 CFR 240.14a-12)\n\n¨ Pre-commencement communications pursuant to Rule 14d-2(b) under\nthe Exchange Act (17 CFR 240.14d-2(b))\n\n¨ Pre-commencement communications pursuant to Rule 13e-4(c) under\nthe Exchange Act (17 CFR 240.13e-4(c))\n\n \n\nSecurities registered pursuant to Section 12(b) of the Act:\n\n \n\n**Title of each\nclass**\n\n**Trading Symbol(s)**\n\n**Name of each\nexchange on which\nregistered**\n\n**Common stock, par value $0.0001 per share**\n**OBIO**\n**The Nasdaq Global Market**\n\n \n\nIndicate by check mark whether the registrant is\nan emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the\nSecurities Exchange Act of 1934 (§240.12b-2 of this chapter). \n\n \n\nEmerging growth company ¨\n\n \n\nIf an emerging growth company, indicate by check mark if the registrant\nhas elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant\nto Section 13(a) of the Exchange Act. ¨"}